{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:25:19Z","timestamp":1793899519424,"version":"4.8.0"},"reference-count":57,"publisher":"American Society of Hematology","issue":"11","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9,10]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Allogeneic hematopoietic cell transplantation (HCT) has benefited many patients with hematological malignancies and bone marrow failure states. However, graft-versus-host disease (GVHD) and immune incompetence remain significant challenges that limit the use of allogeneic HCT to patients with life-threatening, high-risk disorders because of the significant nonrelapse mortality associated with the treatment. With a greater understanding of the pathophysiology of GVHD, it has become apparent that this disorder represents a dysregulated immune reaction resulting in immune dysfunction, further exacerbated by treatment with immunosuppressive medications and injury to lymphoid tissues where immune recovery and tolerance develop. The emergence of fundamental mechanisms of immune regulation, whose pioneers received the 2025 Nobel Prize in Physiology or Medicine, has resulted in new concepts for improving outcomes for patients and offers the hope that, with a reduction in transplant-related risk, HCT can be offered to more patients with a broader range of immune-mediated disorders. In this review, the history, preclinical studies, and successful translation of CD4+CD25+FoxP3+ regulatory T cells in the context of allogeneic HCT are discussed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/blood.2025029805","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T19:12:36Z","timestamp":1782846756000},"page":"1381-1387","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["CD4+CD25+FOXP3+ regulatory T cells to protect against graft-versus-host disease"],"prefix":"10.1182","volume":"148","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8868-276X","authenticated-orcid":false,"given":"Robert S.","family":"Negrin","sequence":"first","affiliation":[{"name":"1Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7953-853X","authenticated-orcid":false,"given":"Everett H.","family":"Meyer","sequence":"additional","affiliation":[{"name":"2Division of Hematology, Department of Medicine, University of Colorado, Aurora, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"22","key":"2026100111412519000_bib1","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMra1609337","article-title":"Acute graft-versus-host disease - biologic process, prevention, and therapy","volume":"377","author":"Zeiser","year":"2017","journal-title":"N Engl J Med"},{"key":"2026100111412519000_bib2","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nri1879","article-title":"In vivo imaging using bioluminescence: a tool for probing graft-versus-host disease","volume":"6","author":"Negrin","year":"2006","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"2026100111412519000_bib3","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1182\/blood-2005-02-0509","article-title":"In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets","volume":"106","author":"Beilhack","year":"2005","journal-title":"Blood"},{"issue":"5","key":"2026100111412519000_bib4","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1182\/blood-2007-09-112789","article-title":"Prevention of acute graft-versus-host disease by blocking T-cell entry to secondary lymphoid organs","volume":"111","author":"Beilhack","year":"2008","journal-title":"Blood"},{"issue":"4","key":"2026100111412519000_bib5","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1182\/blood-2003-08-2987","article-title":"Transfer of allogeneic CD62L- memory T cells without graft-versus-host disease","volume":"103","author":"Chen","year":"2004","journal-title":"Blood"},{"issue":"1","key":"2026100111412519000_bib6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1172\/JCI17601","article-title":"Memory CD4+ T cells do not induce graft-versus-host disease","volume":"112","author":"Anderson","year":"2003","journal-title":"J Clin Invest"},{"issue":"11","key":"2026100111412519000_bib7","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1200\/JCO.21.01755","article-title":"Naive T-cell depletion to prevent chronic graft-versus-host disease","volume":"40","author":"Bleakley","year":"2022","journal-title":"J Clin Oncol"},{"issue":"24","key":"2026100111412519000_bib8","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1182\/blood-2013-03-489757","article-title":"A distinct evolution of the T-cell repertoire categorizes treatment refractory gastrointestinal acute graft-versus-host disease","volume":"121","author":"Meyer","year":"2013","journal-title":"Blood"},{"issue":"25","key":"2026100111412519000_bib9","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1182\/blood-2014-07-587477","article-title":"Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS","volume":"124","author":"Kanakry","year":"2014","journal-title":"Blood"},{"issue":"9","key":"2026100111412519000_bib10","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1172\/JCI200423395","article-title":"CD4+ Tregs and immune control","volume":"114","author":"Fehervari","year":"2004","journal-title":"J Clin Invest"},{"key":"2026100111412519000_bib11","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0092-8674(00)80856-9","article-title":"Regulatory T cells: key controllers of immunologic self-tolerance","volume":"101","author":"Sakaguchi","year":"2000","journal-title":"Cell"},{"key":"2026100111412519000_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-61737-979-6_1","article-title":"Regulatory T cells: history and perspective","volume":"707","author":"Sakaguchi","year":"2011","journal-title":"Methods Mol Biol"},{"key":"2026100111412519000_bib13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.immunol.25.022106.141711","article-title":"The biology of NKT cells","volume":"25","author":"Bendelac","year":"2006","journal-title":"Annu Rev Immunol"},{"issue":"22","key":"2026100111412519000_bib14","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1182\/blood-2014-05-576017","article-title":"CD4+ invariant natural killer T cells protect from murine GVHD lethality through expansion of donor CD4+CD25+FoxP3+ regulatory T cells","volume":"124","author":"Schneidawind","year":"2014","journal-title":"Blood"},{"issue":"2","key":"2026100111412519000_bib15","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.smim.2006.01.007","article-title":"Tr1 cells: from discovery to their clinical application","volume":"18","author":"Battaglia","year":"2006","journal-title":"Semin Immunol"},{"issue":"7","key":"2026100111412519000_bib16","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1002\/eji.201040394","article-title":"NKT cells, Treg, and their interactions in bone marrow transplantation","volume":"40","author":"Kohrt","year":"2010","journal-title":"Eur J Immunol"},{"key":"2026100111412519000_bib17","doi-asserted-by":"crossref","first-page":"805177","DOI":"10.3389\/fimmu.2022.805177","article-title":"Establishment of chimerism and organ transplant tolerance in laboratory animals: safety and efficacy of adaptation to humans","volume":"13","author":"Lowsky","year":"2022","journal-title":"Front Immunol"},{"key":"2026100111412519000_bib18","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1084\/jem.20020399","article-title":"Donor type CD4+CD25+ regulatory T cells suppress lethal acute graft vs host disease after allogeneic bone marrow transplanation","volume":"196","author":"Hoffmann","year":"2002","journal-title":"J Exp Med"},{"key":"2026100111412519000_bib19","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nm915","article-title":"CD4(+)CD25(+) regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation","volume":"9","author":"Edinger","year":"2003","journal-title":"Nat Med"},{"issue":"10","key":"2026100111412519000_bib20","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1182\/blood.V99.10.3493","article-title":"The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality","volume":"99","author":"Taylor","year":"2002","journal-title":"Blood"},{"key":"2026100111412519000_bib21","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1084\/jem.20020090","article-title":"CD4(+)CD25(+) immunoregulatory T cells: new therapeutics for graft-versus-host disease","volume":"196","author":"Cohen","year":"2002","journal-title":"J Exp Med"},{"issue":"4","key":"2026100111412519000_bib22","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1053\/bbmt.2003.50027","article-title":"Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response","volume":"9","author":"Jones","year":"2003","journal-title":"Biol Blood Marrow Transpl"},{"issue":"11","key":"2026100111412519000_bib23","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1172\/JCI17702","article-title":"Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia","volume":"112","author":"Trenado","year":"2003","journal-title":"J Clin Invest"},{"issue":"6","key":"2026100111412519000_bib24","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1182\/blood-2006-08-044529","article-title":"In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation","volume":"109","author":"Nguyen","year":"2007","journal-title":"Blood"},{"issue":"2","key":"2026100111412519000_bib25","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1182\/blood-2007-07-103895","article-title":"The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation","volume":"111","author":"Nguyen","year":"2008","journal-title":"Blood"},{"issue":"12","key":"2026100111412519000_bib26","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1182\/blood-2004-05-1850","article-title":"L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection","volume":"104","author":"Taylor","year":"2004","journal-title":"Blood"},{"issue":"5","key":"2026100111412519000_bib27","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1182\/blood-2004-05-2044","article-title":"Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD","volume":"105","author":"Ermann","year":"2005","journal-title":"Blood"},{"issue":"14","key":"2026100111412519000_bib28","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood.2022017982","article-title":"Analysis of the T-cell repertoire and transcriptome identifies mechanisms of regulatory T-cell suppression of GVHD","volume":"141","author":"Lohmeyer","year":"2023","journal-title":"Blood"},{"issue":"11","key":"2026100111412519000_bib29","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.bbmt.2017.07.009","article-title":"Clinical-grade-expanded regulatory T cells prevent graft-versus-host disease while allowing a powerful T cell-dependent graft-versus-leukemia effect in murine models","volume":"23","author":"Del Papa","year":"2017","journal-title":"Biol Blood Marrow Transpl"},{"issue":"1","key":"2026100111412519000_bib30","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/bmt.2015.215","article-title":"High proportions of regulatory T cells in PBSC grafts predict improved survival after allogeneic haematopoietic SCT","volume":"51","author":"Danby","year":"2016","journal-title":"Bone Marrow Transpl"},{"issue":"8","key":"2026100111412519000_bib31","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1182\/blood-2015-06-653667","article-title":"Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect","volume":"127","author":"Brunstein","year":"2016","journal-title":"Blood"},{"issue":"14","key":"2026100111412519000_bib32","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1182\/blood-2010-10-311894","article-title":"Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation","volume":"117","author":"Di Ianni","year":"2011","journal-title":"Blood"},{"issue":"7","key":"2026100111412519000_bib33","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.20060772","article-title":"CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells","volume":"203","author":"Liu","year":"2006","journal-title":"J Exp Med"},{"issue":"10","key":"2026100111412519000_bib34","doi-asserted-by":"crossref","first-page":"e127244","DOI":"10.1172\/jci.insight.127244","article-title":"Transplantation of donor grafts with defined ratio of conventional and regulatory T cells in HLA-matched recipients","volume":"4","author":"Meyer","year":"2019","journal-title":"Jci Insight"},{"key":"2026100111412519000_bib35","doi-asserted-by":"crossref","first-page":"102685","DOI":"10.1016\/j.coi.2025.102685","article-title":"Regulatory T cell approaches for graft-versus-host disease prevention","volume":"98","author":"Bader","year":"2026","journal-title":"Curr Opin Immunol"},{"issue":"3","key":"2026100111412519000_bib36","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1182\/blood-2010-07-293795","article-title":"Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics","volume":"117","author":"Brunstein","year":"2011","journal-title":"Blood"},{"issue":"1","key":"2026100111412519000_bib37","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/ajt.13456","article-title":"Discarded human thymus is a novel source of stable and long-lived therapeutic regulatory T cells","volume":"16","author":"Dijke","year":"2016","journal-title":"Am J Transpl"},{"issue":"6","key":"2026100111412519000_bib38","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.stem.2024.05.004","article-title":"Human iPSC-derived CD4(+) Treg-like cells engineered with chimeric antigen receptors control GvHD in a xenograft model","volume":"31","author":"Yano","year":"2024","journal-title":"Cell Stem Cell"},{"issue":"4","key":"2026100111412519000_bib39","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1182\/blood-2014-03-564401","article-title":"HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse","volume":"124","author":"Martelli","year":"2014","journal-title":"Blood"},{"key":"2026100111412519000_bib40","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1182\/bloodadvances.2020003739","article-title":"Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia","volume":"5","author":"Pierini","year":"2021","journal-title":"Blood Adv"},{"issue":"5","key":"2026100111412519000_bib41","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1182\/bloodadvances.2023011625","article-title":"Single-center randomized trial of T-reg graft alone vs T-reg graft plus tacrolimus for the prevention of acute GVHD","volume":"8","author":"Bader","year":"2024","journal-title":"Blood Adv"},{"issue":"18","key":"2026100111412519000_bib42","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1182\/blood.2024026446","article-title":"Donor regulatory T-cell therapy to prevent graft-versus-host disease","volume":"145","author":"Meyer","year":"2025","journal-title":"Blood"},{"issue":"11","key":"2026100111412519000_bib43","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1182\/blood.2025031313","article-title":"Orca-T vs allogeneic hematopoietic stem cell transplantation (Precision-T): a multicenter, randomized phase 3 trial","volume":"147","author":"Meyer","year":"2026","journal-title":"Blood"},{"issue":"13","key":"2026100111412519000_bib44","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1182\/blood-2012-04-424135","article-title":"Correlation between NIH composite skin score, patient-reported skin score, and outcome: results from the Chronic GVHD Consortium","volume":"120","author":"Jacobsohn","year":"2012","journal-title":"Blood"},{"issue":"4","key":"2026100111412519000_bib45","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1200\/JCO.21.02293","article-title":"Randomized phase III BMT CTN trial of calcineurin inhibitor-free chronic graft-versus-host disease interventions in myeloablative hematopoietic cell transplantation for hematologic malignancies","volume":"40","author":"Luznik","year":"2022","journal-title":"J Clin Oncol"},{"issue":"2","key":"2026100111412519000_bib46","first-page":"123.e1","article-title":"Kidney function after hematopoietic cell transplantation with Orca-T, cyclophosphamide, or methotrexate graft-versus-host disease prophylaxis: a single-center retrospective study","volume":"32","author":"Ziolkowski","year":"2026","journal-title":"Transpl Cell Ther"},{"issue":"22","key":"2026100111412519000_bib47","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1056\/NEJMoa1108188","article-title":"Interleukin-2 and regulatory T cells in graft-versus-host disease","volume":"365","author":"Koreth","year":"2011","journal-title":"N Engl J Med"},{"issue":"21","key":"2026100111412519000_bib48","doi-asserted-by":"crossref","first-page":"5786","DOI":"10.1182\/bloodadvances.2021006625","article-title":"A phase 1 study of donor regulatory T-cell infusion plus low-dose interleukin-2 for steroid-refractory chronic graft-vs-host disease","volume":"6","author":"Whangbo","year":"2022","journal-title":"Blood Adv"},{"issue":"11","key":"2026100111412519000_bib49","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1182\/blood.2022018440","article-title":"Prevention of acute GVHD using an orthogonal IL-2\/IL-2R\u03b2 system to selectively expand regulatory T cells in vivo","volume":"141","author":"Ramos","year":"2023","journal-title":"Blood"},{"issue":"22","key":"2026100111412519000_bib50","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1182\/blood.2025028418","article-title":"Pretransplant targeting of TNFRSF25 and CD25 stimulates recipient Tregs in target tissues, ameliorating GVHD post-HSCT","volume":"146","author":"McManus","year":"2025","journal-title":"Blood"},{"issue":"21","key":"2026100111412519000_bib51","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1182\/bloodadvances.2019000286","article-title":"Blockade of TIM-1 on the donor graft ameliorates graft-versus-host disease following hematopoietic cell transplantation","volume":"3","author":"Iliopoulou","year":"2019","journal-title":"Blood Adv"},{"issue":"8","key":"2026100111412519000_bib52","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.3390\/molecules29081801","article-title":"Novel JAK inhibitors to reduce graft-versus-host disease after allogeneic hematopoietic cell transplantation in a preclinical mouse model","volume":"29","author":"Kim","year":"2024","journal-title":"Molecules"},{"issue":"21","key":"2026100111412519000_bib53","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1182\/blood.2025031545","article-title":"Regulatory-like FOXP3+Helios+ CD4+ T conventional cells correlate with T cell activation after Orca-T immunotherapy","volume":"147","author":"Bader","year":"2026","journal-title":"Blood"},{"issue":"8","key":"2026100111412519000_bib54","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ajt.2023.01.030","article-title":"Enforced gut homing of murine regulatory T cells reduces early graft-versus-host disease severity","volume":"23","author":"Larson","year":"2023","journal-title":"Am J Transpl"},{"issue":"4","key":"2026100111412519000_bib55","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1172\/JCI82771","article-title":"Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor","volume":"126","author":"MacDonald","year":"2016","journal-title":"J Clin Invest"},{"issue":"769","key":"2026100111412519000_bib56","doi-asserted-by":"crossref","first-page":"eadj9331","DOI":"10.1126\/scitranslmed.adj9331","article-title":"Human OX40L-CAR-T(regs) target activated antigen-presenting cells and control T cell alloreactivity","volume":"16","author":"Rui","year":"2024","journal-title":"Sci Transl Med"},{"key":"2026100111412519000_bib57","article-title":"Graft-versus-host disease prophylaxis shapes T cell biology and immune reconstitution after hematopoietic cell transplant","author":"Siegel","year":"26  2025","journal-title":"medRxiv"}],"updated-by":[{"DOI":"10.1182\/blood.2026036647","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T00:00:00Z","timestamp":1793836800000}}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/148\/11\/1381\/2588056\/blood_bld-2025-029805-c-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/148\/11\/1381\/2588056\/blood_bld-2025-029805-c-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:46:08Z","timestamp":1790869568000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/148\/11\/1381\/569433\/CD4-CD25-FOXP3-regulatory-T-cells-to-protect"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":57,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,9,10]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2025029805","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9,10]]},"published":{"date-parts":[[2026,9,10]]}}}